← Evidence map

ReviewDrug design, development and therapy2013

Aflibercept in wet AMD: specific role and optimal use.

F Semeraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

57 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

NCT02797704phase 1/phase 26 enrolled2017NCT04588948phase 20 enrolled2020
Full record →Abstract, authors, funding and every citing paper · PMID 23990705